Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Shire Share News (SHP)
SHP Share
Price
SHP Share
News
SHP Share
Chat
SHP Share
Trades
SHP
Live RNS
SHP Share
Charts
SHP Broker
Ratings
SHP Directors
Deals
SHP Financial
Diary
SHP
Fundamentals
SHP Short
Positions
SHP
Media
SHP Company
Research
SHP Company
Timeline
- There is currently no data for SHP
Wednesday round-up
Latest SHP News
- UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push
6 Sep 2019 - UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt
14 Aug 2019 - Takeda kicks off sale of Western European drugs - sources
17 Jul 2019 - Japan's Takeda expects binding offers for Latam business by end of May -sources
16 May 2019 - Nikkei snaps 7-day losing streak helped by China's stimulus hopes
15 May 2019 - Nikkei hobbled by trade worries, disappointing earnings
15 May 2019 - UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal
14 May 2019 - Japan's Takeda expects annual loss on Shire deal
14 May 2019
Related News
LONDON MARKET CLOSE: FTSE 100 edges up while US jobs data lifts dollar
(Alliance News) - The FTSE 100 clung on to modest gains on Friday despite weak mining stocks, but Wall Street headed south after stronger-than-expecte...
LONDON MARKET CLOSE: Oil price climbs as Middle East tensions flare
(Alliance News) - The FTSE 100 closed lower on Wednesday amid renewed strength in oil prices as hopes for peace in the Middle East faded once more ami...
WINNERS & LOSERS: Howden's acquisition; B&M signals recovery on track
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Wednesday.
Shire News
UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push
* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms ...
UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt
FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus ma...
Takeda kicks off sale of Western European drugs - sources
By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders fo...
Japan's Takeda expects binding offers for Latam business by end of May -sources
By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by...
Nikkei snaps 7-day losing streak helped by China's stimulus hopes
* Gains may be short-lived - analyst * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi Estate jumps on share buyback, governance reform B...
Nikkei hobbled by trade worries, disappointing earnings
* Nikkei down slightly after 7 losing sessions * Uncertainties over U.S.-China standoff keep investors on edge * Takeda Pharma, Nissan sink after earn...
UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal
* 193 bln Y op loss forecast this yr vs 227.5 bln profit view of analysts * Shire acquisition made Takeda one of the world's most indebted drugmakers ...
Japan's Takeda expects annual loss on Shire deal
TOKYO, May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books cost...
Follow the stocks
